MIM
Marco Investment Management Portfolio holdings
AUM
$1.2B
This Quarter Return
+11.43%
1 Year Return
+22.28%
3 Year Return
+87.03%
5 Year Return
+157.96%
10 Year Return
+313.92%
AUM
$539M
AUM Growth
+$539M
(+6.8%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
182
New
11
Increased
30
Reduced
100
Closed
6
Top Buys
| 1 |
UnitedHealth
UNH
|
$5.81M |
| 2 |
Goldman Sachs
GS
|
$2.56M |
| 3 |
Broadcom
AVGO
|
$2.49M |
| 4 |
International Paper
IP
|
$936K |
| 5 |
Cracker Barrel
CBRL
|
$509K |
Top Sells
| 1 |
Cigna
CI
|
$2.53M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
$2.29M |
| 3 |
Amgen
AMGN
|
$2.16M |
| 4 |
Apple
AAPL
|
$1.28M |
| 5 |
Schwab International Equity ETF
SCHF
|
$1.21M |
Sector Composition
| 1 | Technology | 23.1% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 11.41% |
| 4 | Consumer Staples | 9.45% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares Select Dividend ETF
DVY
$20.6B
| $301K | 0.06% |
3,062
-335
| -10% | -$32.9K |
|
152
RTX Corp
RTX
$212B
| $296K | 0.06% |
2,296
-4,751
| -67% | -$612K |
|
153
Weyerhaeuser
WY
$17.9B
| $290K | 0.05% |
10,999
| – | – |
|
154
Mondelez International
MDLZ
$79.7B
| $286K | 0.05% |
5,719
-500
| -8% | -$25K |
|
155
Graco
GGG
$14B
| $277K | 0.05% |
5,584
-9,100
| -62% | -$451K |
|
156
Eli Lilly
LLY
$656B
| $277K | 0.05% |
2,135
| – | – |
|
157
3M
MMM
$82B
| $262K | 0.05% |
1,260
+85
| +7% | +$17.7K |
|
158
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$1.47B
| $248K | 0.05% |
18,766
| – | – |
|
159
lululemon athletica
LULU
$23.9B
| $246K | 0.05% |
+1,500
| New | +$246K |
|
160
Equity Residential
EQR
$24.5B
| $242K | 0.04% |
3,214
| – | – |
|
161
DexCom
DXCM
$29B
| $238K | 0.04% |
2,000
| – | – |
|
162
Exponent
EXPO
$3.66B
| $234K | 0.04% |
4,050
| – | – |
|
163
Yum! Brands
YUM
$40.2B
| $230K | 0.04% |
2,302
| – | – |
|
164
Nike
NKE
$110B
| $219K | 0.04% |
+2,600
| New | +$219K |
|
165
iShares Morningstar Growth ETF
ILCG
$2.89B
| $217K | 0.04% |
+1,189
| New | +$217K |
|
166
Descartes Systems
DSGX
$8.45B
| $211K | 0.04% |
+5,800
| New | +$211K |
|
167
Pembina Pipeline
PBA
$21.8B
| $205K | 0.04% |
+5,570
| New | +$205K |
|
168
Omnicell
OMCL
$1.47B
| $202K | 0.04% |
+2,500
| New | +$202K |
|
169
iShares Core S&P 500 ETF
IVV
$654B
| $201K | 0.04% |
+708
| New | +$201K |
|
170
Novo Nordisk
NVO
$249B
| $200K | 0.04% |
+3,825
| New | +$200K |
|
171
CVR Partners
UAN
$944M
| $101K | 0.02% |
25,500
+3,000
| +13% | +$11.9K |
|
172
Akebia Therapeutics
AKBA
$822M
| $97K | 0.02% |
11,783
-1,871
| -14% | -$15.4K |
|
173
Ford
F
$46.5B
| $88K | 0.02% |
10,000
-3,000
| -23% | -$26.4K |
|
|
PVL
174
Permianville Royalty Trust
PVL
$65.3M
| $40K | 0.01% |
12,000
| – | – |
|
175
DarioHealth
DRIO
$21.7M
| $37K | 0.01% |
50,000
| – | – |
|